Skip to main content
. 2021 Dec 9;18(9):1625–1634. doi: 10.1002/alz.12528

TABLE 2.

Diagnostic incidence of AD and ADRD by sex and race/ethnicity in the Multiethnic Cohort Study (1999‐2014; N = 105,796)

Events Competing events* Person‐years ASDIR Hazard Ratio (95% CI)
Model 1 Model 2 Model 3
(a) AD
Women 4561 12,266 592,678 7.32 1.17 (1.11–1.23) 1.12 (1.07–1.18) 1.27 (1.21–1.33)
Men 2803 13,389 454,877 6.08 1.00 (ref) 1.00 (ref) 1.00 (ref)
P for sex (all races combined) <0.0001 <0.0001 <0.0001
Women
African American 1002 2832 88,315 9.54 1.37 (1.26–1.50) 1.28 (1.17–1.40) 1.25 (1.14–1.37)
Filipino 111 395 25,420 4.58 0.71 (0.58–0.86) 0.72 (0.59–0.87) 0.77 (0.63–0.93)
Japanese American 1454 2918 187,200 6.60 0.94 (0.87–1.02) 0.94 (0.87–1.02) 1.06 (0.97–1.15)
Latino 769 2022 114,723 7.76 1.15 (1.04–1.26) 1.05 (0.95–1.17) 1.11 (1.00–1.24)
Native Hawaiian 224 908 36,786 7.65 1.16 (1.00–1.34) 1.10 (0.95–1.28) 1.07 (0.92–1.24)
White 1001 3191 140,234 6.85 1.00 (ref) 1.00 (ref) 1.00 (ref)
P for race/ethnicity < 0.0001 < 0.0001 < 0.0001
Men
African American 402 1989 44,755 7.85 1.27 (1.12–1.43) 1.26 (1.10–1.43) 1.19 (1.05–1.35)
Filipino 80 528 22,211 3.56 0.60 (0.47–0.75) 0.63 (0.50–0.80) 0.69 (0.55–0.87)
Japanese American 927 3962 147,930 5.55 0.89 (0.81–0.98) 0.90 (0.81–1.00) 0.99 (0.90–1.10)
Latino 553 2535 99,739 6.19 1.04 (0.93–1.16) 1.00 (0.88–1.13) 1.08 (0.96–1.22)
Native Hawaiian 160 926 26,555 7.99 1.35 (1.13–1.60) 1.27 (1.06–1.52) 1.22 (1.02–1.46)
White 681 3449 113,687 6.07 1.00 (ref) 1.00 (ref) 1.00 (ref)
P for race/ethnicity <0.0001 <0.0001 <0.0001
P for race/ethnicity by sex 0.26 0.46 0.52
(b) ADRD
Women 9792 9406 574,019 17.01 1.03 (1.00–1.11) 1.01 (0.98–1.04) 1.15 (1.12–1.19)
Men 6618 10,769 443,287 15.33 1.00 (ref) 1.00 (ref) 1.00 (ref)
P for sex (all races combined) <0.0001 0.49 <0.0001
Women
African American 2175 2061 84,398 22.92 1.39 (1.31–1.47) 1.24 (1.16–1.32) 1.22 (1.15–1.30)
Filipino 278 322 24,783 12.53 0.79 (0.70–0.89) 0.79 (0.69–0.89) 0.84 (0.74–0.95)
Japanese American 2994 2192 181,323 14.76 0.89 (0.84–0.94) 0.87 (0.82–0.92) 0.97 (0.92–1.03)
Latino 1609 1609 111,684 16.79 1.06 (0.99–1.13) 0.93 (0.87–1.00) 0.99 (0.92–1.06)
Native Hawaiian 522 749 35,778 19.33 1.21 (1.10–1.33) 1.13 (1.03–1.25) 1.06 (0.96–1.17)
White 2214 2473 136,053 16.38 1.00 (ref) 1.00 (ref) 1.00 (ref)
P for race/ethnicity <0.0001 <0.0001 <0.0001
Men
African American 1005 1557 43,054 21.51 1.37 (1.26–1.48) 1.31 (1.21–1.42) 1.25 (1.15–1.35)
Filipino 208 440 21,859 9.72 0.63 (0.54–0.72) 0.64 (0.55–0.74) 0.71 (0.62–0.83)
Japanese American 2151 3114 144,076 13.84 0.87 (0.81–0.93) 0.85 (0.80–0.91) 0.94 (0.88–1.01)
Latino 1250 2066 97,610 14.71 0.96 (0.89–1.03) 0.87 (0.81–0.95) 0.95 (0.88–1.03)
Native Hawaiian 375 785 25,870 19.44 1.30 (1.16–1.46) 1.19 (1.06–1.33) 1.12 (0.99–1.25)
White 1629 2807 110,818 15.50 1.00 (ref) 1.00 (ref) 1.00 (ref)
P for race/ethnicity <0.0001 <0.0001 <0.0001
P for race/ethnicity by sex 0.045 0.055 0.39

Note: Model 1: Cox proportional hazards regression model adjusted for age at cohort entry and age at Medicare follow‐up start.

Model 2: includes Model 1 adjustments + education, history of heart disease, stroke, diabetes or hypertension at cohort baseline, and mean annual Medicare usage (in‐patient, out‐patient) over follow‐up.

Model 3: includes Model 2 adjustments in a competing risk model accounting for deaths due to other causes.

P for race/ethnicity for the overall racial/ethnic difference was obtained from the Wald chi‐square test for the main effect of race/ethnicity in the sex‐stratified Cox regression model for AD or ADRD. P for race/ethnicity by sex for the heterogeneity of the racial/ethnic differences between women and men was obtained based on the interaction term between sex and race/ethnicity in the combined Cox regression model for AD or ADRD.

ASDIR (age‐standardized diagnostic incidence rate per 1000 person‐years).

Abbreviations: AD, Alzheimer's disease; ADRD, Alzheimer's disease and related dementia; CI, confidence interval.

*

Competing events refer to deaths due to other (non‐ADRD) causes among individuals who have not been diagnosed for AD or ADRD.